논문KCI 등재
Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision im munotherapy and TACE therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Correspondence to editorial on “Molecular classifica tion of hepatocellular carcinoma based on zoned met abolic feature and oncogenic signaling pathway”Masatoshi Kudo, Naoshi Nishida, Tomoko Aoki대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathwayAtsushi Takebe, Hirokazu Chishina, Hiroshi Ida, Ippei Matsumoto, Kazuko Sakai, Kazuomi Ueshima, Kazuto Nishio, Keiko Kamei, Kohei Hanaoka, Masahiro Morita, Masahiro Takita, Masakatsu Tsurusaki, Masatoshi Kudo, Naoshi Nishida, Naoto Fujiwara, Satoru Hagiwara, Takaaki Murase, Takuya Nakai, Tomoko Aoki, Yasunori Minami, Yutaka Kurebayashi대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”Eun Ji Jang, Pil Soo Sung대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호A novel link between tumor cell metabolism and pa tient prognosis: Editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”Eun Ji Jang, Pil Soo Sung대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinomaHideki Iwamoto, Hironori Koga, Takumi Kawaguchi대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-re sistant subtype with distinct molecular featuresBeodeul Kang, Chan Kim, Chansik An, Dahyeon Son, Da-Yeon Lee, Dong Jun Shin, Gae Hoon Jo, Gwangil Kim, Haeyoun Kang, Hannah Yang, Hong Jae Chon, Ho Yeong Lim, Hyeyeong Kim, Ilhwan Kim, Incheon Kang, Jung Sun Kim, Junho Park, Ju-Seog Lee, Sanghoon Jung, Seonjeong Woo, Sohyun Hwang, So Jung Kong, Sung Hwan Lee, Won Suk Lee, Woo Young Kwon, Youngsoo Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12